QCLVX
Price
$32.89
Change
+$0.29 (+0.89%)
Updated
Jun 6 closing price
Net Assets
1.66B
VIVAX
Price
$67.51
Change
+$0.65 (+0.97%)
Updated
Jun 6 closing price
Net Assets
188.77B
Interact to see
Advertisement

QCLVX vs VIVAX

Header iconQCLVX vs VIVAX Comparison
Open Charts QCLVX vs VIVAXBanner chart's image
Federated Hermes MDT Large Cap Value C
Price$32.89
Change+$0.29 (+0.89%)
VolumeN/A
Net Assets1.66B
Vanguard Value Index I
Price$67.51
Change+$0.65 (+0.97%)
VolumeN/A
Net Assets188.77B
QCLVX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
QCLVX vs. VIVAX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QCLVX is a StrongBuy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. QCLVX (1.66B). VIVAX pays higher dividends than QCLVX: VIVAX (2.16) vs QCLVX (0.20). QCLVX was incepted earlier than VIVAX: QCLVX (7 years) vs VIVAX (33 years). QCLVX (1.92) is less costly to investors than VIVAX (0.17). QCLVX is a more actively managed with annual turnover of: 69.00 vs. VIVAX (9.00). QCLVX has a lower initial minimum investment than VIVAX: QCLVX (1500) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 6.81 vs. QCLVX (1.86). VIVAX return over 5 years is better than : 58.70 vs. QCLVX (27.43).
QCLVXVIVAXQCLVX / VIVAX
Total Expense Ratio1.810.171,065%
Annual Report Gross Expense Ratio1.920.171,129%
Fund Existence7 years33 years-
Gain YTD5.5741.238450%
Front LoadN/AN/A-
Min. Initial Investment1500300050%
Min. Initial Investment IRAN/AN/A-
Net Assets1.66B189B1%
Annual Yield % from dividends0.202.169%
Returns for 1 year1.866.8127%
Returns for 3 years9.2118.5150%
Returns for 5 years27.4358.7047%
Returns for 10 yearsN/A102.90-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABUS3.480.08
+2.35%
Arbutus Biopharma Corp
WSFS53.081.21
+2.33%
WSFS Financial Corp
MNSB18.20N/A
N/A
MainStreet Bancshares
PATH13.21-0.05
-0.38%
UiPath
FAMI1.87-0.06
-3.11%
Farmmi Inc